• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺微小乳头状癌(黑色墨水标记)。

Papillary thyroid microcarcinoma (Black Ink).

作者信息

Trapanese Ersilio, De Bartolomeis Carmine, Angrisani Basilio, Tarro Giulio

机构信息

Interventional Ultrasound of Breast Oncology Screening, ASL Salerno, Salerno, Italy.

Endocrine Surgery and General Surgery Specialist, University Pisa, Pisa, Italy.

出版信息

Oncotarget. 2018 Jun 26;9(49):29275-29283. doi: 10.18632/oncotarget.25621.

DOI:10.18632/oncotarget.25621
PMID:30018751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6044379/
Abstract

We report a case of a 58-year-old Caucasian woman affected by papillary thyroid microcarcinoma (PTMC) of the left-lobe of the gland with very small size (Ø 0.3 cm). The characteristics with the Diagnostic Imaging using Ultrasonography, ADF (Advanced Dynamic Flow), and fine-needle-aspiration cytology (FNAC) are discussed, comprising a very small micro-focus of radial shape, with markedly hypoechoic echostructure, irregular margins, supplemented by peripheral vessel formation. It acquires an image which appears similar to a brisk visualization of a dark ink stain in the normal thyroid weave. We call such a pattern "Black Ink" with ultrasonographic image and believe consistent with the infiltrating variant of papillary thyroid microcarcinoma if associated with malignant cytology after FNA.

摘要

我们报告了一例58岁的高加索女性,其左叶甲状腺患有微小乳头状癌(PTMC),肿瘤尺寸非常小(直径0.3厘米)。本文讨论了使用超声、ADF(高级动态血流)和细针穿刺细胞学检查(FNAC)进行诊断成像的特征,包括一个非常小的放射状微病灶,具有明显低回声的回声结构、边缘不规则,并伴有周边血管形成。它呈现出一种类似于正常甲状腺组织中深色墨水污渍快速显影的图像。我们将这种超声图像模式称为“黑墨水”模式,并认为如果在细针穿刺后伴有恶性细胞学特征,则与甲状腺微小乳头状癌的浸润性变体相符。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/be1916f75a8f/oncotarget-09-29275-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/655b71bbb6e8/oncotarget-09-29275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/67cd1ccb1ca8/oncotarget-09-29275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/db1eb9a7b961/oncotarget-09-29275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/2e5d308f6eb2/oncotarget-09-29275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/a8f3d9d35fdf/oncotarget-09-29275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/a1b4e888f466/oncotarget-09-29275-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/1fdb73ead00a/oncotarget-09-29275-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/3de1a1fd3813/oncotarget-09-29275-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/1604dffaa7ad/oncotarget-09-29275-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/a2d18f3005fe/oncotarget-09-29275-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/be1916f75a8f/oncotarget-09-29275-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/655b71bbb6e8/oncotarget-09-29275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/67cd1ccb1ca8/oncotarget-09-29275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/db1eb9a7b961/oncotarget-09-29275-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/2e5d308f6eb2/oncotarget-09-29275-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/a8f3d9d35fdf/oncotarget-09-29275-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/a1b4e888f466/oncotarget-09-29275-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/1fdb73ead00a/oncotarget-09-29275-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/3de1a1fd3813/oncotarget-09-29275-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/1604dffaa7ad/oncotarget-09-29275-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/a2d18f3005fe/oncotarget-09-29275-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edb8/6044379/be1916f75a8f/oncotarget-09-29275-g011.jpg

相似文献

1
Papillary thyroid microcarcinoma (Black Ink).甲状腺微小乳头状癌(黑色墨水标记)。
Oncotarget. 2018 Jun 26;9(49):29275-29283. doi: 10.18632/oncotarget.25621.
2
Papillary thyroid microcarcinoma in a thyroid pyramidal lobe.甲状腺锥状叶内的甲状腺微小乳头状癌。
Ultrasonography. 2014 Oct;33(4):303-6. doi: 10.14366/usg.14026. Epub 2014 Jul 13.
3
Can galectin-3 be a useful marker for conventional papillary thyroid microcarcinoma?半乳糖凝集素-3能否作为传统甲状腺微小乳头状癌的有用标志物?
Diagn Cytopathol. 2016 Feb;44(2):103-7. doi: 10.1002/dc.23408. Epub 2015 Dec 17.
4
Preoperative Tc-99m-pertechnetate scan visualization of gross neck metastases from microcarcinoma papillare and another papillary carcinoma of tall cell variant scintigraphically presented like small warm nodule in Graves disease patient.术前 Tc-99m-过锝酸盐扫描显示 Graves 病患者中微小癌乳头状癌和另一种高细胞变体乳头状癌的大体颈部转移灶呈放射性核素扫描表现为小而温暖的结节。
Clin Nucl Med. 2010 Nov;35(11):858-61. doi: 10.1097/RLU.0b013e3181f4991e.
5
Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.术前超声检查和血清促甲状腺激素对预测甲状腺微小乳头状癌或可疑甲状腺微小乳头状癌甲状腺结节中央淋巴结转移的价值
Tumour Biol. 2016 Jun;37(6):7453-9. doi: 10.1007/s13277-015-4535-3. Epub 2015 Dec 17.
6
Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.将颈部肿块鉴定为隐匿性对侧甲状腺乳头状微小癌的淋巴结转移:甲状腺球蛋白检测在细针穿刺抽吸中的关键作用
Thyroid. 2009 May;19(5):531-3. doi: 10.1089/thy.2009.0049.
7
Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases?甲状腺乳头状癌:微小癌与癌、意外癌与非意外癌——它们是不同的疾病吗?
Clin Endocrinol (Oxf). 2005 Nov;63(5):577-81. doi: 10.1111/j.1365-2265.2005.02386.x.
8
Is fine needle aspiration really not necessary in patients with thyroid nodules ≤ 1 cm with highly suspicious features on ultrasonography and candidates for active surveillance?对于超声检查有高度可疑特征且适合进行主动监测的甲状腺结节≤1cm的患者,细针穿刺真的没有必要吗?
Diagn Cytopathol. 2017 Apr;45(4):294-296. doi: 10.1002/dc.23673. Epub 2017 Feb 20.
9
Isolated submandibular metastasis from a contralateral thyroid papillary microcarcinoma: an unusual case.对侧甲状腺乳头状微小癌致孤立性颏下转移:不常见病例。
Dentomaxillofac Radiol. 2009 Dec;38(8):546-9. doi: 10.1259/dmfr/30751894.
10
Secondary infection and ischemic necrosis after fine needle aspiration for a painful papillary thyroid carcinoma: a case report.细针穿刺后疼痛性甲状腺乳头状癌的继发感染和缺血性坏死:一例报告
Acta Cytol. 2006 Mar-Apr;50(2):217-20. doi: 10.1159/000325936.

引用本文的文献

1
Left Supraclavicular Lymph Node Metastasis from Ovarian Cancer Associated with Papillary Thyroid Microcarcinoma, a Confusing Pathology-Essential Role of Functional Imaging.卵巢癌伴甲状腺微小乳头状癌左锁骨上淋巴结转移,一种易混淆的病理情况——功能成像的重要作用
Diagnostics (Basel). 2020 Apr 30;10(5):270. doi: 10.3390/diagnostics10050270.

本文引用的文献

1
Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: a case report.甲状腺全切除及放射性碘消融术后43年甲状腺乳头状癌复发:一例报告
Thyroid Res. 2017 Oct 10;10:8. doi: 10.1186/s13044-017-0043-4. eCollection 2017.
2
Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study.韩国多中心研究中甲状腺微小乳头状癌的长期复发及其危险因素
J Clin Endocrinol Metab. 2017 Feb 1;102(2):625-633. doi: 10.1210/jc.2016-2287.
3
Could Tumor Size Be A Predictor for Papillary Thyroid Microcarcinoma: a Retrospective Cohort Study.
肿瘤大小能否作为甲状腺微小乳头状癌的预测指标:一项回顾性队列研究
Asian Pac J Cancer Prev. 2015;16(18):8625-8. doi: 10.7314/apjcp.2015.16.18.8625.
4
Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.家族性甲状腺乳头状癌的临床病理特征与预后——一项大规模、配对病例对照研究
Clin Endocrinol (Oxf). 2016 Apr;84(4):598-606. doi: 10.1111/cen.12859. Epub 2015 Aug 11.
5
Characterization of papillary thyroid microcarcinomas using sonographic features in malignant papillary thyroid cancer: a retrospective analysis.利用超声特征对甲状腺微小乳头状癌进行表征:恶性甲状腺乳头状癌的回顾性分析
Medicine (Baltimore). 2015 May;94(21):e841. doi: 10.1097/MD.0000000000000841.
6
Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?所有甲状腺微小乳头状癌都应考虑行中央区淋巴结清扫吗?
Asian J Surg. 2016 Oct;39(4):197-201. doi: 10.1016/j.asjsur.2015.02.006. Epub 2015 Apr 22.
7
Italian consensus for the classification and reporting of thyroid cytology.意大利甲状腺细胞病理学分类与报告共识
J Endocrinol Invest. 2014 Jun;37(6):593-9. doi: 10.1007/s40618-014-0062-0. Epub 2014 May 1.
8
Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective.滤泡细胞源性甲状腺癌的侵袭性变体:细胞病理学家的观点
Cancer Cytopathol. 2014 Jul;122(7):484-503. doi: 10.1002/cncy.21417. Epub 2014 Mar 24.
9
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.乳头状微癌的预后因素,重点是组织学分型:148 例临床病理研究。
Thyroid. 2014 Feb;24(2):245-53. doi: 10.1089/thy.2012.0645. Epub 2013 Sep 4.
10
Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.侵袭性甲状腺微小乳头状癌与甲状腺外侵犯和淋巴结转移相关:一项基于人群的分析。
Thyroid. 2013 Oct;23(10):1305-11. doi: 10.1089/thy.2012.0563. Epub 2013 Sep 14.